Thursday 10 Jul, 2025 07:26 PM
Site map | Locate Us | Login
   TCS' PAT climbs 4% QoQ to Rs 12,760 cr in Q1 FY26; declares dividend of Rs 11/shr    GP Eco Solutions hits the roof after bagging Rs 121-cr solar order    Krystal Integrated hits the roof on securing Rs 20-cr facility management contract for JPNI airport    Desco Infratech gains on bagging Rs 2-cr of order    JTL Inds jumps on expansion plan    Metropolis Healthcare Ltd leads losers in 'A' group    Eimco Elecon (India) Ltd leads losers in 'B' group    Hero MotoCorp appoints Kausalya Nandakumar as CBO of emerging mobility unit    Jagatjit Industries CEO & CFO Anil Vanjani resigns    Volumes jump at Campus Activewear Ltd counter    IREDA gains after Govt nod to raise capital gains bonds    Shilpa Medicare gains on receiving SFDA GMP certification for Bengaluru facility    HDFC Asset Management Company Ltd rises for third consecutive session    Inox Wind Ltd rises for third straight session    JSW Energy Ltd up for third consecutive session 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Emcure Pharma gains after Sanand facility gets zero observations from USFDA
10-Jul-25   09:50 Hrs IST

The inspection conducted from 30 June 2025 to 08 July 2025 and concluded without issuance of Form 483, indicating zero observations.

Pune-based Emcure Pharmaceuticals is a leading Indian pharma company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products.

The company's consolidated net profit jumped 64.1% to Rs 188.96 crore on 19.5% increase in net sales to Rs 2,116.25 crore in Q4 FY25 over Q4 FY24.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 42561339
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited